Docetaxel and gemcitabine combination in
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: A retrospective analysis
β
Jacques-Olivier Bay; Isabelle Ray-Coquard; JΓ©rΓ΄me Fayette; Serge Leyvraz; Stepha
π
Article
π
2006
π
John Wiley and Sons
π
French
β 165 KB
## Abstract Advanced softβtissue sarcomas are usually resistant to cytotoxic agents such as doxorubicin and ifosfamide. Antitumor activity has been observed for gemcitabine and docetaxel combination. We conducted a retrospective study on 133 patients (58 males/75 females) with unresectable or metas